These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19712557)

  • 41. [Diagnosis and treatment of antiphospholipid antibody-related recurrent spontaneous abortion and analysis of therapeutic drugs and pregnancy outcome in 75 patients with antiphospholipid syndrome].
    Li XY; Zhao JX; Liu XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):956-961. PubMed ID: 30562764
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases.
    Alijotas-Reig J; Esteve-Valverde E; Ferrer-Oliveras R; Sáez-Comet L; Lefkou E; Mekinian A; Belizna C; Ruffatti A; Tincani A; Marozio L; Espinosa G; Cervera R; Ríos-Garcés R; De Carolis S; Latino O; LLurba E; Chighizola CB; Gerosa M; Pengo V; Lundelin K; Rovere-Querini P; Canti V; Mayer-Pickel K; Reshetnyak T; Hoxha A; Tabacco S; Stojanovich L; Gogou V; Varoudis A; Arnau A; Ruiz-Hidalgo D; Trapé J; Sos L; Stoppani C; Martí-Cañamares A; Farran-Codina I;
    Autoimmun Rev; 2019 Apr; 18(4):406-414. PubMed ID: 30772493
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The antiphospholipid syndrome in the 21st century].
    Ruiz-Irastorza G; Martinez-Berriotxoa A; Egurbide MV
    Med Clin (Barc); 2009 Sep; 133(10):390-6. PubMed ID: 19375117
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current insights in obstetric antiphospholipid syndrome.
    Schreiber K; Radin M; Sciascia S
    Curr Opin Obstet Gynecol; 2017 Dec; 29(6):397-403. PubMed ID: 28915160
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss.
    Clark CA; Spitzer KA; Laskin CA; Crowther MR; Ginsberg JS
    Obstet Gynecol; 2010 Oct; 116(4):997-998. PubMed ID: 20859172
    [No Abstract]   [Full Text] [Related]  

  • 46. Bemiparin versus low dose aspirin for management of recurrent early pregnancy losses due to antiphospholipd antibody syndrome.
    Alalaf S
    Arch Gynecol Obstet; 2012 Mar; 285(3):641-7. PubMed ID: 21842174
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomized trial of aspirin versus aspirin and heparin in pregnant women with the antiphospholipid syndrome.
    Cohen H
    Ann Med Interne (Paris); 1996 Sep; 147 Suppl 1():44. PubMed ID: 8992939
    [No Abstract]   [Full Text] [Related]  

  • 48. Pregnancy outcomes for women with non-criteria antiphospholipid syndrome after anticoagulant therapy.
    Lo HW; Chen CJ; Tsai EM
    Eur J Obstet Gynecol Reprod Biol; 2020 Jan; 244():205-207. PubMed ID: 31753470
    [No Abstract]   [Full Text] [Related]  

  • 49. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.
    Laskin CA; Spitzer KA; Clark CA; Crowther MR; Ginsberg JS; Hawker GA; Kingdom JC; Barrett J; Gent M
    J Rheumatol; 2009 Feb; 36(2):279-87. PubMed ID: 19208560
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of anti-thrombotic therapy for recurrent pregnancy loss due to anti-phospholipid syndrome.
    Fawad S
    J Ayub Med Coll Abbottabad; 2010; 22(3):197-200. PubMed ID: 22338455
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recurrent miscarriage and thrombophilia: an update.
    McNamee K; Dawood F; Farquharson R
    Curr Opin Obstet Gynecol; 2012 Aug; 24(4):229-34. PubMed ID: 22729089
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Postpartum thrombosis after a successful pregnancy in a recurrent aborter strongly positive for antiphospholipid antibodies.
    Katano K; Aoki K; Ogasawara M; Aoyama T; Suzumori K
    Acta Obstet Gynecol Scand; 1998 Mar; 77(3):354-6. PubMed ID: 9539288
    [No Abstract]   [Full Text] [Related]  

  • 53. Use of D-dimer measurement to guide anticoagulant treatment in recurrent pregnancy loss associated with antiphospholipid syndrome.
    Bao SH; Sheng SL; Liao H; Zhou Q; Frempong ST; Tu WY
    Am J Reprod Immunol; 2017 Dec; 78(6):. PubMed ID: 29024233
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Pregnancy in primary antiphospholipid syndrome. Proposal for a common management protocol].
    el Kouri D; Winer N; Sagot P; Hamidou M; Boog G; Barrier J
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(8):828-31. PubMed ID: 9026512
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage.
    Clark P; Walker ID; Langhorne P; Crichton L; Thomson A; Greaves M; Whyte S; Greer IA;
    Blood; 2010 May; 115(21):4162-7. PubMed ID: 20237316
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autoimmunity: effectiveness of treatments for pregnant women with APS.
    Gelber SE; Salmon JE
    Nat Rev Rheumatol; 2010 Apr; 6(4):187-9. PubMed ID: 20357787
    [No Abstract]   [Full Text] [Related]  

  • 57. Treatment of pregnant women with recurrent miscarriage associated with phospholipid antibodies. During pregnancy, heparin should be stopped during labour and then restarted soon after delivery.
    Piette JC; Huong DL; Wechsler B
    BMJ; 1997 Aug; 315(7104):372-3; author reply 373. PubMed ID: 9270479
    [No Abstract]   [Full Text] [Related]  

  • 58. Heparin and aspirin in pregnant Sudanese women with recurrent miscarriage associated with antiphospholipid antibodies.
    A/Magid YM; Elussein EA; Omer MM; Samaan SI; A/Rahim F; Adam I
    Afr J Reprod Health; 2007 Aug; 11(2):95-8. PubMed ID: 20690292
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preliminary prospective study of the endocrinology of conception cycles and early pregnancy in women with antiphospholipid syndrome treated with low molecular weight heparin.
    Prakash A; Laird S; Li TC; Ledger WL
    Fertil Steril; 2006 Jan; 85(1):165-70. PubMed ID: 16412749
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enoxaparin for prevention of unexplained recurrent miscarriage: a multicenter randomized double-blind placebo-controlled trial.
    Pasquier E; de Saint Martin L; Bohec C; Chauleur C; Bretelle F; Marhic G; Le Gal G; Debarge V; Lecomte F; Denoual-Ziad C; Lejeune-Saada V; Douvier S; Heisert M; Mottier D
    Blood; 2015 Apr; 125(14):2200-5. PubMed ID: 25636341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.